Differences between revisions 3 and 4
Revision 3 as of 2006-11-20 20:01:10
Size: 2654
Editor: lfrq80
Comment:
Revision 4 as of 2006-11-21 22:18:02
Size: 2685
Editor: lfrq80
Comment: Updated importance
Deletions are marked like this. Additions are marked like this.
Line 54: Line 54:
This notation most often appears in explicit maps. ..//TranscriptionShorthand is a special case of this notation. This is generally important, and the notation most often appears in explicit maps. ../TranscriptionShorthand is a special case of this notation.

Use Case Name : ../ProductAppears

For Feature : MIMEditor

Editors: DavidKane

TableOfContents([2])

Summary

Users wants to describe a species in a pathway without complete detail to its origins

Step-by-Step User Action

  1. User specifies a protein or small molecule
  2. User specifies a product appears relationship
  3. User optionally specifies the evidence for this reaction

Visual Aides

The notation for this relationship is the following:

attachment:productsappears1_061117_dwk.PNG

The product that appears is on the right side of the arrow:

attachment:productsappears2_061117_dwk.PNG

Here is an example, in context:

attachment:productsappears3_061117_dwk.PNG

Requirements for Cytoscape

TBD

Importance

This is generally important, and the notation most often appears in explicit maps. ../TranscriptionShorthand is a special case of this notation.

attachment:productsappears4_061117_dwk.PNG

Other Examples

Comments

PageComment2

Molecular_Interaction_Maps/ProductAppears (last edited 2009-02-12 01:03:08 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux